Brief: Asit Biotech announces approval of follow-up study of clinical trial with hdm-asit+
Aug 16 (Reuters) - ASIT BIOTECH SA ASIT.BR :
* ANNOUNCES THE APPROVAL BY THE REGULATORY AUTHORITIES OF A
FOLLOW-UP STUDY OF THE PHASE I/IIA CLINICAL TRIAL WITH ITS
HDM-ASIT+ PRODUCT CANDIDATE
Source text for Eikon: ID:nBw6j7hY4a
Further company coverage: ASIT.BR
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on European Medical Solutions SA
See all newsBrief: DMS Imaging H1 EBITDA Rises To EUR 2.2 Million
Brief: DMS Imaging Announces Resumption Of Project To Transfer Its Listing Securities On Euronext Growth Market In Paris And Brussels
Brief: DMS Imagining Announces End Of Litigation With Thierry Legon
Brief: DMS Imaging Sees 2023 Revenue At 40 Million Euros
Brief: DMS Imaging Says Fujifilm Healthcare Italy Wins Tender For Its Radiology Tables